Page last updated: 2024-08-22

technetium 99m and myelin oligodendrocyte glycoprotein (35-55)

technetium 99m has been researched along with myelin oligodendrocyte glycoprotein (35-55) in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
De Rycke, R; De Vos, F; Libert, C; Steeland, S; Toussaint, W; Van Imschoot, G; Van Ryckeghem, S; Vandenbroucke, RE; Vanhoutte, L; Vanhove, C	1

Other Studies

1 other study(ies) available for technetium 99m and myelin oligodendrocyte glycoprotein (35-55)

Article	Year
TNFR1 inhibition with a Nanobody protects against EAE development in mice. Scientific reports, 2017, 10-20, Volume: 7, Issue:1 Topics: Animals; Encephalomyelitis, Autoimmune, Experimental; Humans; Immunologic Factors; Male; Mice, Transgenic; Myelin-Oligodendrocyte Glycoprotein; Neuroprotective Agents; Peptide Fragments; Receptors, Tumor Necrosis Factor, Type I; Single-Domain Antibodies; Spinal Cord; Technetium; Tumor Necrosis Factor-alpha; Whole Body Imaging	2017

Article

Year

TNFR1 inhibition with a Nanobody protects against EAE development in mice.

Scientific reports, 2017, 10-20, Volume: 7, Issue:1

Topics: Animals; Encephalomyelitis, Autoimmune, Experimental; Humans; Immunologic Factors; Male; Mice, Transgenic; Myelin-Oligodendrocyte Glycoprotein; Neuroprotective Agents; Peptide Fragments; Receptors, Tumor Necrosis Factor, Type I; Single-Domain Antibodies; Spinal Cord; Technetium; Tumor Necrosis Factor-alpha; Whole Body Imaging

2017